UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15b-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of: May 2021
Commission File Number: 000-51848
(Exact name of registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
3500 – 1055 Dunsmuir Street PO Box 49114 Vancouver BC V7X1H7
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F x Form 40-F o
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes o No x
Indicate by check mark if the Registrant is submitting this Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes o No x
Indicate by check mark whether the registrant by furnishing the information contained in this Form 6-K is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes o No x
Exhibits
The following exhibits are included in this Form 6-K:
Exhibit No. | Description | Date filed on SEDAR |
|
|
|
99.1 | News Release, Avricore Health’s Healthtab TM Signs Distribution Agreement to Expand Pharmacy Network and Test Offering | May 31, 2021 |
99.2 | Interim Financial Statements for the period ended March 31, 2021 and 2020 | May 31, 2021 |
99.3 | Management’s Discussion and Analysis for the period ended March 31, 2021 | May 31, 2021 |
99.4 | May 31, 2021 | |
99.5 | May 31, 2021 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: July 8, 2021 | AVRICORE HEALTH INC. |
|
|
| By: /s/ Kiki Smith |
| Kiki Smith |
| Chief Financial Officer |
2